Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/86585
DC FieldValueLanguage
dc.contributorDepartment of Optometry and Radiography-
dc.creatorLeung, Kin-luen-
dc.identifier.urihttps://theses.lib.polyu.edu.hk/handle/200/2736-
dc.language.isoEnglish-
dc.titleImmunotherapeutic effect of an interleukin-2 immunoconjugate in animal model-
dc.typeThesis-
dcterms.abstractRecombinant antibody-cytokine fusion proteins are immunocytokines that deliver high cytokine concentrations in the targeted tumor microenvironment and thereby effectively stimulate cellular immune responses against human malignancies. Protoon-cogene HER-2/neu is overexpressed in some human breast, ovarian, prostate and lung cancers and associated with poor prognosis. A novel immunocytokine consisting of a recombinant human interleukin-2 (rhIL-2) and a recombinant humanized single chain antibody that combined the VH and VL portions of a murine monoclonal antibody (520C9) specific for human HER-2/neu positive tumors has been developed. The fusion protein H520C9sFv-rhIL-2 in combination with human peripheral blood mononuclear cells effectively inhibited growth and dissemination of subcutaneous xenograft and lung metastases of human HER-2/neu positive ovarian carcinoma in severe combined immunodeficient mice. In addition, histological staining and immunohistochemical analysis of lung metastases in the treatment group of SCID mice with the H520C9sFv-rhIL-2 and human PBM cells demonstrated significant suppression of metastatic tumor growth. A dose dependent response was also demonstrated by the effective inhibition of lung metastases at a dose level of 6 ug H520C9sFv-rhJL-2 instead of 3 ug H520C9sFv-rhIL-2 per injection with 2 x 105 human PBM cells. Such results demonstrated that immunocytokine-directed inter1eukin-2 therapy to tumors sites could be effective in an adjuvant setting for patients with disseminated metastases of human HER-2/neu positive tumors.-
dcterms.accessRightsopen access-
dcterms.educationLevelM.Phil.-
dcterms.extentxiv, 87 leaves : ill. ; 30 cm-
dcterms.issued2003-
dcterms.LCSHHong Kong Polytechnic University -- Dissertations-
dcterms.LCSHInterleukin 2 -- Therapeutic use-
dcterms.LCSHAntibody-toxin conjugates-
dcterms.LCSHImmunotherapy-
Appears in Collections:Thesis
Show simple item record

Page views

9
Citations as of Jun 26, 2022

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.